Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy

被引:21
作者
Jin, Xun [1 ,2 ,3 ]
Zou, Bingwen [4 ]
Luo, Li [1 ,2 ,3 ]
Zhong, Chuanhong [5 ]
Zhang, Peilan [1 ,2 ,3 ]
Cheng, Hao [1 ,2 ,3 ]
Guo, Yanfang [1 ,2 ,3 ]
Gou, Maling [1 ,2 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Sch Med, Dept Thorac Oncol,Canc Ctr, Chengdu, Peoples R China
[5] Luzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Luzhou, Sichuan, Peoples R China
关键词
thioridazine; doxorubicin; codelivery; nanoparticles; breast cancer; DRUG-DELIVERY; CO-DELIVERY; NANOTECHNOLOGY; PERMEABILITY; CHEMOTHERAPY; SIZE;
D O I
10.2147/IJN.S104635
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Cancer chemotherapy can benefit from the combination of different anticancer drugs. Here, we prepared doxorubicin (Dox)- and thioridazine (Thio)-coloaded methoxy poly(ethylene glycol)-poly(L-lactic acid) (MPEG-PLA) nanoparticles (NPs) for breast cancer therapy. These NPs have an average particle size of 27 nm. The drug loading efficiencies of Thio and Dox are 4.71% and 1.98%, respectively. Compared to the treatment of Thio or Dox alone, the combination of Thio and Dox exhibited a synergistic effect in inhibiting the growth of 4T1 breast cancer cells in vitro. In addition, the Thio- and Dox-coloaded MPEG-PLA NPs could efficiently suppress the growth of breast cancer cells in vivo. This study suggests that Thio-and Dox-coloaded MPEG-PLA NPs might have potential applications in breast cancer treatment.
引用
收藏
页码:4545 / 4552
页数:8
相关论文
共 29 条
[1]   Combinatorial drug therapy for cancer in the post-genomic era [J].
Al-Lazikani, Bissan ;
Banerji, Udai ;
Workman, Paul .
NATURE BIOTECHNOLOGY, 2012, 30 (07) :679-691
[2]   Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy [J].
Amreddy, Narsireddy ;
Muralidharan, Ranganayaki ;
Babu, Anish ;
Mehta, Meghna ;
Johnson, Elyse V. ;
Zhao, Yan D. ;
Munshi, Anupama ;
Ramesh, Rajagopal .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 :6773-6788
[3]   Nanotechnology-based drug delivery systems and herbal medicines: a review [J].
Bonifacio, Bruna Vidal ;
da Silva, Patricia Bento ;
dos Santos Ramos, Matheus Aparecido ;
Silveira Negri, Kamila Maria ;
Bauab, Tais Maria ;
Chorilli, Marlus .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :1-15
[4]   NANOTECHNOLOGY Carrying drugs [J].
Bourzac, Katherine .
NATURE, 2012, 491 (7425) :S58-S60
[5]   Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib [J].
Broxterman, Henk J. ;
Gotink, Kristy J. ;
Verheul, Henk M. W. .
DRUG RESISTANCE UPDATES, 2009, 12 (4-5) :114-126
[6]   Doxorubicin conjugated to D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS):: Conjugation chemistry, characterization, in vitro and in vivo evaluation [J].
Cao, Na ;
Feng, Si-Shen .
BIOMATERIALS, 2008, 29 (28) :3856-3865
[7]   Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes [J].
Chithrani, B. Devika ;
Chan, Warren C. W. .
NANO LETTERS, 2007, 7 (06) :1542-1550
[8]   Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer [J].
Espelin, Christopher W. ;
Leonard, Shannon C. ;
Geretti, Elena ;
Wickham, Thomas J. ;
Hendriks, Bart S. .
CANCER RESEARCH, 2016, 76 (06) :1517-1527
[9]   Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer [J].
Gao, Xiang ;
Wang, BiLan ;
Wei, XiaWei ;
Rao, Wang ;
Ai, Fang ;
Zhao, Fen ;
Men, Ke ;
Yang, Bowen ;
Liu, Xingyu ;
Huang, Meijuan ;
Gou, Maling ;
Qian, ZhiYong ;
Huang, Ning ;
Wei, Yuquan .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 :971-982
[10]  
Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1